The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization What is the efficacy of intranasal BPC 157 (Body Protection Compound 157)? When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions Is BPC 157 Banned? Oral vs. Injectable Forms Explained BPC 157: Experimental Peptide Creates Risk for Athletes